Skip to main content
ME

Michael Eisenberg

Dr Michael Eisenberg**semen Analysis as a Health Biomarker**the 1-in-3 Male Causation Gap**six Semen Parameters to Request**testosterone Replacement Destroys Sperm Production
2episodes
2podcasts

We have 2 summarized appearances for Michael Eisenberg so far. Browse all podcasts to discover more episodes.

Featured On 2 Podcasts

Top resources Michael Eisenberg mentions

Books, tools, and gear cited across podcast appearances. Ranked by frequency.

SignalCast may earn commission on purchases via affiliate links on each resource page.

All Appearances

2 episodes

AI Summary

→ WHAT IT COVERS Dr Michael Eisenberg, Stanford urologist and male fertility specialist, joins reproductive endocrinologist Dr Natalie Crawford to examine why male fertility testing is systematically neglected. They cover semen analysis parameters, how sperm health predicts long-term disease risk, the damage caused by unsupervised testosterone use, declining global sperm counts, paternal age effects, and concrete steps men can take to optimize reproductive and overall health. → KEY INSIGHTS - **Semen analysis as a health biomarker:** Sperm health functions as a "check engine light" for overall male health, predicting future chronic disease risk beyond fertility. A Danish study tracking men for up to 50 years found every semen parameter — volume, concentration, motility, morphology — correlated with age of death. Men with low sperm counts show higher rates of psoriasis, rheumatoid arthritis, and metabolic syndrome, even years before diagnosis. A semen analysis provides health intelligence that BMI and smoking status alone cannot. - **The 1-in-3 male causation gap:** Male factors solely explain roughly one-third of infertility cases, contribute to another third alongside female factors, yet current guidelines only recommend semen analysis after a couple fails to conceive for a full year. Surveys of infertile couples show males go unevaluated 25–33% of the time. Couples have undergone up to a year of IUI without a single semen analysis performed, wasting time, money, and emotional resources when a zero-sperm condition was present from the start. - **Six semen parameters to request:** A complete semen analysis covers volume, concentration, motility, morphology, pH, and DNA sperm fragmentation. Most standard clinic and at-home tests omit DNA fragmentation, which measures oxidative damage to sperm DNA and is now recommended by ASRM after two or more pregnancy losses. Total motile sperm count — calculated as volume × concentration × motility percentage — is the most clinically useful summary figure, with 40 million total motile sperm considered the threshold for optimal natural conception odds. - **Testosterone replacement destroys sperm production:** Exogenous testosterone acts as a contraceptive by suppressing FSH and LH signals from the brain, halting spermatogenesis and causing testicular atrophy. Intratesticular testosterone levels need to be roughly 10 times higher than blood levels to support sperm production — injectable TRT cannot replicate this. Recovery after stopping TRT takes 6–12 months and is not guaranteed, particularly after prolonged use. Men at unregulated testosterone clinics routinely receive no semen analysis, no fertility counseling, and no investigation into why testosterone is low. - **Cannabis negatively impacts sperm and pregnancy outcomes:** Daily cannabis use is associated with reduced sperm concentration, motility, and lower embryo development rates in IVF cycles. Women whose partners use cannabis — even if they do not use it themselves — show higher miscarriage rates. In IVF settings, switching from nightly cannabis use to abstinence, then waiting three months for a full spermatogenesis cycle, has produced measurably different outcomes. Edible THC concentrations can exceed smoked forms, making all delivery methods relevant for pregnancy outcome data. - **Paternal age effects begin at 40, accelerate past 50:** The American Society of Reproductive Medicine defines advanced paternal age as over 40. Past age 50, statistically significant increases emerge in autism spectrum disorder, schizophrenia, autosomal dominant conditions like dwarfism, and genomic imprinting disorders. Sperm freezing before age 40 is a low-cost, low-burden intervention — at-home collection kits allow mail-in banking without clinic visits. Each spermatogenesis cycle takes approximately 90 days, meaning sperm quality reflects the preceding three months of lifestyle, health, and exposures. - **Lifestyle changes improve sperm within 90 days:** Unlike eggs, which accumulate damage over decades, sperm regenerate on a roughly three-month cycle, making male fertility one of the most modifiable reproductive variables. Chronic inflammation and insulin resistance are the strongest shared drivers of poor sperm and egg quality. Reducing obesity, eliminating daily cannabis, avoiding heat exposure to the testes, limiting endocrine-disrupting chemical exposure, and addressing conditions like varicocele — present in 40% of infertile men — can produce measurable semen parameter improvements within a single spermatogenesis cycle. → NOTABLE MOMENT Dr Crawford described a couple told to "keep trying" for 18 months before anyone ordered a semen analysis. When testing finally occurred, the male partner had no sperm in his ejaculate due to a congenital absence of the vas deferens — a condition detectable from day one. Every month of waiting was medically futile, and the delay likely cost the woman additional IVF cycles due to her advancing age. 💼 SPONSORS [{"name": "38 Terra", "url": "https://38terra.com"}, {"name": "IM8", "url": "https://im8health.com"}, {"name": "Peak Life", "url": "https://piquelife.com"}, {"name": "Skylight Calendar", "url": "https://myskylight.com"}, {"name": "Function Health", "url": "https://functionhealth.com"}] 🏷️ Male Fertility, Semen Analysis, Sperm Health, Testosterone Replacement Therapy, Paternal Age, Infertility Testing, Reproductive Medicine

AI Summary

→ WHAT IT COVERS Three venture capitalists — Michael Eisenberg (Aleph VC), Mike Granoff (Muneeb), and Larry Covert (Oxcart Ventures) — examine how five US firms capturing 73.1% of Q1 LP commitments signals either the end of venture capital as a craft business or a cyclical concentration wave, while debating AI compute costs, autonomous vehicles, defense tech, and global supply chain realignment. → KEY INSIGHTS - **VC Concentration Math:** Five US firms captured 73.1% of all LP commitments in Q1, up from 12 firms capturing 75% previously. Smaller funds can survive by maintaining double the ownership stakes of larger firms. Ownership percentage is the critical variable — dilution from oversized cap stacks means IPO returns fail to cover losses, breaking the asymmetric upside model that makes venture capital function mathematically. - **Two-Tier VC Strategy:** The industry is splitting into Consensus VC (large firms deploying index-like capital) and Traditional VC (sub-$500M funds taking concentrated, high-conviction bets on non-obvious founders). Smaller funds should target LP bases outside major financial centers — Oxcart raised from large Southern family offices with zero prior venture exposure by traveling the "Southern smile" from Southern California to South Carolina. - **AI Gross Margin Risk:** ARR figures from AI companies obscure negative or thin gross margins because token and compute costs are not software margins. Cursor reportedly ran negative 23% gross margins during rapid growth. Founders and investors should model compute costs as a rising variable tied to energy prices, not a declining one, since grid infrastructure scales far slower than semiconductor demand. - **Edge AI vs. Data Center:** Models trained on real-world data outperform simulation-trained equivalents at a fraction of the size — Nexar's Badass 2.0 model beats NVIDIA's Cosmos by 2.5-3x while being an order of magnitude smaller. Founders building AI products should evaluate whether their use case can run on edge CPUs (Apple M-series, Snapdragon at 50-80 TOPS on 15 watts) rather than defaulting to expensive cloud GPU inference. - **Defense Tech Valuation Caution:** The drone sector now has over 2,000 companies, mirroring the 200 bomb-resistant vehicle firms that emerged during Iraq/Afghanistan — most were absorbed or failed while legacy primes like BAE and Oshkosh waited and acquired best-in-class technology. Investors entering defense tech should prioritize non-obvious infrastructure plays adjacent to national security rather than competing in crowded drone or kinetic hardware categories at inflated valuations. - **Allied Supply Chain Realignment:** Global supply chains are permanently restructuring around sovereign allied networks rather than cost-optimized globalist ones. The UAE is building a 5-gigawatt data center accessible to US companies and NVIDIA chips. Founders in hardware, defense, and materials should map their supply chains now against allied-nation sourcing, as adversarial dependencies in semiconductors, rare earths, and critical components face increasing regulatory and geopolitical disruption over the next decade. → NOTABLE MOMENT Michael Eisenberg argued that the Tel Aviv Stock Exchange will become the equivalent of Nasdaq for the current decade — the destination for mid-sized hardware, defense, and materials companies that cannot meet the $10B+ valuation threshold now effectively required to list on US exchanges, citing its status as the top-performing stock index over three years. 💼 SPONSORS [{"name": "Grasshopper Bank", "url": "https://grasshopper.bank/twist"}, {"name": "PaperOS", "url": "https://paperos.com/twist"}, {"name": "LinkedIn Jobs", "url": "https://linkedin.com/twist"}] 🏷️ Venture Capital Concentration, AI Compute Costs, Defense Tech Investing, Edge AI, Supply Chain Realignment, Tel Aviv Stock Exchange

Never miss Michael Eisenberg's insights

Subscribe to get AI-powered summaries of Michael Eisenberg's podcast appearances delivered to your inbox weekly.

Start Free Today

No credit card required • Free tier available